Literature DB >> 2680347

Clinical uses of hyaluronan.

E A Balazs1, J L Denlinger.   

Abstract

The availability of elastoviscous solutions of highly purified hyaluronan has created two new therapeutic methods in human and veterinary medicine: viscosurgery and viscosupplementation. Viscosurgical tools and implants are widely used in ophthalmology and have been suggested for use in otology. Visco-supplementation of joint fluid using elastoviscous hyaluronan solutions is widely used in the treatment of equine traumatic arthritis. It was also suggested for use in idiopathic osteoarthritis in humans, but this application has not received wide acceptance. Cross-linked forms of hyaluronan have been developed and given the generic name of hylans. Water-insoluble soft gels of hylans are ideally suitable as viscosurgical implants to prevent postoperative adhesions and to control scar formation. Hylan solutions are being used in arthroscopic viscosurgery. Hylan devices in various forms (gels, tubes, membranes) have been used in animal studies for matrix engineering, the purpose of which is to control and direct tissue regeneration and augmentation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2680347     DOI: 10.1002/9780470513774.ch16

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  25 in total

Review 1.  Hyaluronate in rheumatology and orthopaedics: is there a role?

Authors:  R K Strachan; P Smith; D L Gardner
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

2.  What's New in Fillers in 2010?

Authors: 
Journal:  J Clin Aesthet Dermatol       Date:  2010-08

Review 3.  Hyaluronan biology: A complex balancing act of structure, function, location and context.

Authors:  Stavros Garantziotis; Rashmin C Savani
Journal:  Matrix Biol       Date:  2019-02-23       Impact factor: 11.583

4.  [Hyaluronic acid fillers in dermatology].

Authors:  Wolfgang G Philipp-Dormston
Journal:  Hautarzt       Date:  2018-06       Impact factor: 0.751

5.  Lip nodules caused by hyaluronic acid filler injection: report of three cases.

Authors:  Shokoufeh Shahrabi Farahani; John Sexton; Jeffrey D Stone; Kevin Quinn; Sook-Bin Woo
Journal:  Head Neck Pathol       Date:  2011-10-08

6.  Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.

Authors:  Paolo P Provenzano; Carlos Cuevas; Amy E Chang; Vikas K Goel; Daniel D Von Hoff; Sunil R Hingorani
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

7.  Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities.

Authors:  Bryan P Toole
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

8.  Characterization of esterified hyaluronan-gelatin polymer composites suitable for chondrogenic differentiation of mesenchymal stem cells.

Authors:  Peter Angele; Rainer Müller; Detlef Schumann; Carsten Englert; Johannes Zellner; Brian Johnstone; Jung Yoo; Joachim Hammer; Johann Fierlbeck; Martin K Angele; Michael Nerlich; Richard Kujat
Journal:  J Biomed Mater Res A       Date:  2009-11       Impact factor: 4.396

9.  Soft tissue augmentation in dermatology - 2009 update.

Authors:  Michael H Gold
Journal:  J Cutan Aesthet Surg       Date:  2010-01

Review 10.  Role of hyaluronan in glioma invasion.

Authors:  Jong Bae Park; Hee-Jin Kwak; Seung-Hoon Lee
Journal:  Cell Adh Migr       Date:  2008-07-21       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.